In January the FDA published draft cybersecurity recommendations for marketed medical devices to protect patient safety.

What’s new in this draft FDA guidance document:

Manufacturer’s Responsibilities

This guidance emphasizes that medical device manufacturers should monitor, identify and address cybersecurity vulnerabilities. This draft FDA document highlights that it is essential for device manufacturers to implement comprehensive cybersecurity risk management programs. These programs should focus on addressing the vulnerabilities which could permit the unauthorized access, modification, misuse, or denial of use of information that is stored, accessed, or transferred from a medical device, and could impact patient safety.

Download the FDA Guidance document here: Postmarket Management of Cybersecurity in Medical Devices

You may also be interested in the Pre-market guidance released in 2014

Not sure what to make of these new guidance documents? Talk to our CSV experts about how it may affect your medical device project.

Like it? Share it:

You may also like

Warning Letter Roundup - December 2016
19 December, 2016

The FDA sends Warning Letters and 483s to companies that significantly violate FDA regulations. We gather those related ...

Sponsoring & Speaking at 2018 MWSQA Annual Conference
17 June, 2018

We are thrilled to announce another speaking opportunity for Deb Bartel this summer. She will be speaking at the Midwest...

How Are You Managing Your Postmarket Cybersecurity Vulnerabilities For Medical Devices?
5 January, 2017

At the end of 2016, the FDA published Guidance for Industry and FDA Staff, Postmarket Management of Cybersecurity in Med...